nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—Lenalidomide—hematologic cancer	0.0853	0.1	CbGbCtD
Phenylbutazone—PTGS2—Thalidomide—hematologic cancer	0.0456	0.0535	CbGbCtD
Phenylbutazone—PTGS1—Bortezomib—hematologic cancer	0.0442	0.0519	CbGbCtD
Phenylbutazone—SLC22A8—Mercaptopurine—hematologic cancer	0.0412	0.0484	CbGbCtD
Phenylbutazone—PTGS1—Thalidomide—hematologic cancer	0.0385	0.0452	CbGbCtD
Phenylbutazone—PTGS1—Ifosfamide—hematologic cancer	0.0339	0.0398	CbGbCtD
Phenylbutazone—PTGS1—Imatinib—hematologic cancer	0.0324	0.038	CbGbCtD
Phenylbutazone—PTGS2—Triamcinolone—hematologic cancer	0.0316	0.0371	CbGbCtD
Phenylbutazone—CYP2C9—Bexarotene—hematologic cancer	0.029	0.0341	CbGbCtD
Phenylbutazone—PTGS2—Betamethasone—hematologic cancer	0.0271	0.0318	CbGbCtD
Phenylbutazone—CYP2C9—Idarubicin—hematologic cancer	0.024	0.0282	CbGbCtD
Phenylbutazone—SLC22A11—Methotrexate—hematologic cancer	0.0231	0.0272	CbGbCtD
Phenylbutazone—PTGS2—Cisplatin—hematologic cancer	0.0195	0.0229	CbGbCtD
Phenylbutazone—PTGS2—Etoposide—hematologic cancer	0.0192	0.0225	CbGbCtD
Phenylbutazone—CYP2C9—Bortezomib—hematologic cancer	0.0178	0.0209	CbGbCtD
Phenylbutazone—CYP3A4—Bexarotene—hematologic cancer	0.0169	0.0198	CbGbCtD
Phenylbutazone—PTGS1—Etoposide—hematologic cancer	0.0162	0.019	CbGbCtD
Phenylbutazone—PTGS2—Dexamethasone—hematologic cancer	0.0158	0.0185	CbGbCtD
Phenylbutazone—CYP3A4—Busulfan—hematologic cancer	0.0157	0.0184	CbGbCtD
Phenylbutazone—CYP3A4—Lomustine—hematologic cancer	0.0157	0.0184	CbGbCtD
Phenylbutazone—CYP2C9—Thalidomide—hematologic cancer	0.0155	0.0182	CbGbCtD
Phenylbutazone—CYP2C9—Teniposide—hematologic cancer	0.0148	0.0174	CbGbCtD
Phenylbutazone—CYP3A4—Thiotepa—hematologic cancer	0.014	0.0164	CbGbCtD
Phenylbutazone—CYP2C9—Ifosfamide—hematologic cancer	0.0136	0.016	CbGbCtD
Phenylbutazone—SLC22A8—Methotrexate—hematologic cancer	0.0135	0.0158	CbGbCtD
Phenylbutazone—CYP2C9—Imatinib—hematologic cancer	0.013	0.0153	CbGbCtD
Phenylbutazone—CYP2C9—Nilotinib—hematologic cancer	0.0118	0.0139	CbGbCtD
Phenylbutazone—CYP3A4—Methoxsalen—hematologic cancer	0.0109	0.0128	CbGbCtD
Phenylbutazone—CYP3A4—Bortezomib—hematologic cancer	0.0103	0.0121	CbGbCtD
Phenylbutazone—CYP3A4—Daunorubicin—hematologic cancer	0.00989	0.0116	CbGbCtD
Phenylbutazone—SLC22A6—Methotrexate—hematologic cancer	0.00938	0.011	CbGbCtD
Phenylbutazone—CYP3A4—Cytarabine—hematologic cancer	0.00872	0.0102	CbGbCtD
Phenylbutazone—CYP3A4—Teniposide—hematologic cancer	0.00859	0.0101	CbGbCtD
Phenylbutazone—CYP3A4—Ifosfamide—hematologic cancer	0.00793	0.00932	CbGbCtD
Phenylbutazone—CYP3A4—Imatinib—hematologic cancer	0.00757	0.0089	CbGbCtD
Phenylbutazone—CYP3A4—Ruxolitinib—hematologic cancer	0.00713	0.00838	CbGbCtD
Phenylbutazone—CYP3A4—Nilotinib—hematologic cancer	0.00688	0.00809	CbGbCtD
Phenylbutazone—CYP3A4—Vinorelbine—hematologic cancer	0.00682	0.00802	CbGbCtD
Phenylbutazone—CYP2C9—Cisplatin—hematologic cancer	0.00663	0.00779	CbGbCtD
Phenylbutazone—PTGS2—ovarian follicle—hematologic cancer	0.00658	0.279	CbGeAlD
Phenylbutazone—CYP3A4—Triamcinolone—hematologic cancer	0.00624	0.00733	CbGbCtD
Phenylbutazone—CYP3A4—Dasatinib—hematologic cancer	0.00608	0.00715	CbGbCtD
Phenylbutazone—CYP3A4—Mitoxantrone—hematologic cancer	0.00601	0.00706	CbGbCtD
Phenylbutazone—CYP2C9—Dexamethasone—hematologic cancer	0.00536	0.0063	CbGbCtD
Phenylbutazone—CYP3A4—Betamethasone—hematologic cancer	0.00535	0.00629	CbGbCtD
Phenylbutazone—CYP3A4—Prednisolone—hematologic cancer	0.00528	0.00621	CbGbCtD
Phenylbutazone—CYP3A4—Prednisone—hematologic cancer	0.00499	0.00586	CbGbCtD
Phenylbutazone—CYP3A4—Irinotecan—hematologic cancer	0.00473	0.00556	CbGbCtD
Phenylbutazone—CYP3A4—Vinblastine—hematologic cancer	0.00421	0.00494	CbGbCtD
Phenylbutazone—CYP3A4—Vincristine—hematologic cancer	0.00413	0.00486	CbGbCtD
Phenylbutazone—CYP3A4—Etoposide—hematologic cancer	0.00379	0.00445	CbGbCtD
Phenylbutazone—CYP3A4—Dexamethasone—hematologic cancer	0.00311	0.00366	CbGbCtD
Phenylbutazone—CYP3A4—Doxorubicin—hematologic cancer	0.00258	0.00304	CbGbCtD
Phenylbutazone—PTGIS—lung—hematologic cancer	0.00258	0.109	CbGeAlD
Phenylbutazone—PTGIS—testis—hematologic cancer	0.00243	0.103	CbGeAlD
Phenylbutazone—PTGIS—lymph node—hematologic cancer	0.00176	0.0747	CbGeAlD
Phenylbutazone—SLC22A8—hematopoietic system—hematologic cancer	0.0014	0.0593	CbGeAlD
Phenylbutazone—SLC22A8—blood—hematologic cancer	0.000928	0.0393	CbGeAlD
Phenylbutazone—CYP2C9—hematopoietic system—hematologic cancer	0.00091	0.0386	CbGeAlD
Phenylbutazone—Sulfinpyrazone—ABCC3—hematologic cancer	0.000858	0.343	CrCbGaD
Phenylbutazone—PTGS1—hematopoietic system—hematologic cancer	0.000831	0.0352	CbGeAlD
Phenylbutazone—PTGS2—hematopoietic system—hematologic cancer	0.000794	0.0337	CbGeAlD
Phenylbutazone—CYP3A4—hematopoietic system—hematologic cancer	0.000694	0.0294	CbGeAlD
Phenylbutazone—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000659	0.209	CbGdCrCtD
Phenylbutazone—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000659	0.209	CbGdCrCtD
Phenylbutazone—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000644	0.205	CbGdCrCtD
Phenylbutazone—CYP2C9—blood—hematologic cancer	0.000603	0.0256	CbGeAlD
Phenylbutazone—PTGS1—blood—hematologic cancer	0.000551	0.0233	CbGeAlD
Phenylbutazone—PTGS2—blood—hematologic cancer	0.000526	0.0223	CbGeAlD
Phenylbutazone—PTGS2—bone marrow—hematologic cancer	0.000509	0.0216	CbGeAlD
Phenylbutazone—PTGS1—lung—hematologic cancer	0.000483	0.0205	CbGeAlD
Phenylbutazone—PTGS2—lung—hematologic cancer	0.000461	0.0195	CbGeAlD
Phenylbutazone—CYP3A4—blood—hematologic cancer	0.00046	0.0195	CbGeAlD
Phenylbutazone—PTGS1—testis—hematologic cancer	0.000455	0.0193	CbGeAlD
Phenylbutazone—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000397	0.126	CbGdCrCtD
Phenylbutazone—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000397	0.126	CbGdCrCtD
Phenylbutazone—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000388	0.124	CbGdCrCtD
Phenylbutazone—PTGS1—lymph node—hematologic cancer	0.00033	0.014	CbGeAlD
Phenylbutazone—PTGS2—lymph node—hematologic cancer	0.000316	0.0134	CbGeAlD
Phenylbutazone—Phenoxybenzamine—SLC22A1—hematologic cancer	0.000276	0.11	CrCbGaD
Phenylbutazone—Diphenhydramine—SLC22A1—hematologic cancer	0.000231	0.0924	CrCbGaD
Phenylbutazone—Fosphenytoin—ALB—hematologic cancer	0.000203	0.0814	CrCbGaD
Phenylbutazone—Protriptyline—ABCB1—hematologic cancer	0.00019	0.0759	CrCbGaD
Phenylbutazone—Sulfinpyrazone—ABCB1—hematologic cancer	0.000173	0.0694	CrCbGaD
Phenylbutazone—Phenprocoumon—ALB—hematologic cancer	0.000139	0.0558	CrCbGaD
Phenylbutazone—Fentanyl—ABCB1—hematologic cancer	9.46e-05	0.0378	CrCbGaD
Phenylbutazone—Clobazam—ABCB1—hematologic cancer	9.41e-05	0.0376	CrCbGaD
Phenylbutazone—Phenytoin—ALB—hematologic cancer	8.99e-05	0.036	CrCbGaD
Phenylbutazone—Phenytoin—ABCB1—hematologic cancer	8.58e-05	0.0343	CrCbGaD
Phenylbutazone—Methadone—ABCB1—hematologic cancer	6.49e-05	0.0259	CrCbGaD
Phenylbutazone—PTGS2—Metabolism—CRABP1—hematologic cancer	1.53e-05	0.000128	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC22A1—hematologic cancer	1.53e-05	0.000128	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KRAS—hematologic cancer	1.53e-05	0.000127	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.53e-05	0.000127	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SDC1—hematologic cancer	1.51e-05	0.000126	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.51e-05	0.000126	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALOX5—hematologic cancer	1.49e-05	0.000125	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.49e-05	0.000125	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LCK—hematologic cancer	1.47e-05	0.000122	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NUP98—hematologic cancer	1.44e-05	0.000121	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.44e-05	0.00012	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—H3F3A—hematologic cancer	1.44e-05	0.00012	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—DCK—hematologic cancer	1.41e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ASNS—hematologic cancer	1.41e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.41e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CA—hematologic cancer	1.4e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ADCY7—hematologic cancer	1.4e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NCOA3—hematologic cancer	1.4e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FHL2—hematologic cancer	1.4e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRKCZ—hematologic cancer	1.4e-05	0.000117	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NUP214—hematologic cancer	1.39e-05	0.000116	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.38e-05	0.000115	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AGRN—hematologic cancer	1.38e-05	0.000115	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CALR—hematologic cancer	1.37e-05	0.000115	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCG2—hematologic cancer	1.36e-05	0.000114	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTR—hematologic cancer	1.36e-05	0.000114	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CD44—hematologic cancer	1.36e-05	0.000113	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NQO1—hematologic cancer	1.36e-05	0.000113	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PARP1—hematologic cancer	1.35e-05	0.000113	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ENO2—hematologic cancer	1.34e-05	0.000112	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HDC—hematologic cancer	1.33e-05	0.000111	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.33e-05	0.000111	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FBXW7—hematologic cancer	1.33e-05	0.000111	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMMR—hematologic cancer	1.3e-05	0.000109	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—IDH2—hematologic cancer	1.3e-05	0.000109	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HDAC2—hematologic cancer	1.3e-05	0.000109	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CXCR4—hematologic cancer	1.3e-05	0.000109	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HRAS—hematologic cancer	1.3e-05	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTT1—hematologic cancer	1.3e-05	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD44—hematologic cancer	1.29e-05	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYCS—hematologic cancer	1.29e-05	0.000107	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.28e-05	0.000107	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.28e-05	0.000107	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CBL—hematologic cancer	1.27e-05	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SDC1—hematologic cancer	1.27e-05	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.26e-05	0.000105	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—hematologic cancer	1.24e-05	0.000104	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.23e-05	0.000103	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.23e-05	0.000102	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CDA—hematologic cancer	1.22e-05	0.000102	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.21e-05	0.000101	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HSP90AA1—hematologic cancer	1.21e-05	0.000101	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.2e-05	9.98e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA9—hematologic cancer	1.19e-05	9.95e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ACP5—hematologic cancer	1.19e-05	9.95e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.18e-05	9.82e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CA—hematologic cancer	1.17e-05	9.81e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PC—hematologic cancer	1.17e-05	9.8e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT1—hematologic cancer	1.17e-05	9.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.15e-05	9.6e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—hematologic cancer	1.15e-05	9.57e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.14e-05	9.55e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.13e-05	9.47e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GBA—hematologic cancer	1.13e-05	9.47e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTP1—hematologic cancer	1.13e-05	9.46e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—IDH1—hematologic cancer	1.12e-05	9.36e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.11e-05	9.25e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.11e-05	9.25e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TXN—hematologic cancer	1.11e-05	9.25e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.1e-05	9.15e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GRB2—hematologic cancer	1.09e-05	9.12e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFA—hematologic cancer	1.09e-05	9.1e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.08e-05	9.05e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NQO1—hematologic cancer	1.08e-05	9e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CD44—hematologic cancer	1.08e-05	9e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KITLG—hematologic cancer	1.07e-05	8.97e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCB1—hematologic cancer	1.07e-05	8.95e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.06e-05	8.82e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT5A—hematologic cancer	1.05e-05	8.76e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.04e-05	8.7e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTM1—hematologic cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NCOR1—hematologic cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN2B—hematologic cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTAP—hematologic cancer	1.04e-05	8.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYCS—hematologic cancer	1.02e-05	8.52e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.01e-05	8.46e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.01e-05	8.46e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.01e-05	8.46e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD86—hematologic cancer	1.01e-05	8.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HES1—hematologic cancer	9.93e-06	8.29e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALOX5—hematologic cancer	9.88e-06	8.25e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NCOR1—hematologic cancer	9.87e-06	8.24e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF1—hematologic cancer	9.76e-06	8.15e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FOXO1—hematologic cancer	9.62e-06	8.03e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFRB—hematologic cancer	9.6e-06	8.02e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—hematologic cancer	9.6e-06	8.01e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NUP98—hematologic cancer	9.57e-06	7.99e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFRA—hematologic cancer	9.45e-06	7.89e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRKCG—hematologic cancer	9.42e-06	7.86e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JAK1—hematologic cancer	9.42e-06	7.86e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ADCY7—hematologic cancer	9.29e-06	7.75e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOA3—hematologic cancer	9.29e-06	7.75e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FHL2—hematologic cancer	9.25e-06	7.72e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NUP214—hematologic cancer	9.22e-06	7.7e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—hematologic cancer	9.2e-06	7.68e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.13e-06	7.62e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.13e-06	7.62e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AGRN—hematologic cancer	9.07e-06	7.57e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTR—hematologic cancer	9.04e-06	7.54e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCG2—hematologic cancer	9.04e-06	7.54e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTP1—hematologic cancer	9e-06	7.51e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ENO2—hematologic cancer	8.86e-06	7.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—hematologic cancer	8.72e-06	7.28e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.7e-06	7.27e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TERT—hematologic cancer	8.7e-06	7.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HLA-A—hematologic cancer	8.7e-06	7.26e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMMR—hematologic cancer	8.6e-06	7.18e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—IDH2—hematologic cancer	8.6e-06	7.18e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTT1—hematologic cancer	8.59e-06	7.17e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCB1—hematologic cancer	8.51e-06	7.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PDGFB—hematologic cancer	8.49e-06	7.09e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.46e-06	7.06e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SDC1—hematologic cancer	8.4e-06	7.01e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TSC2—hematologic cancer	8.3e-06	6.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTM1—hematologic cancer	8.27e-06	6.9e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NCOR1—hematologic cancer	8.27e-06	6.9e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.11e-06	6.77e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.08e-06	6.75e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.02e-06	6.7e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGFR3—hematologic cancer	7.98e-06	6.66e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.92e-06	6.61e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA9—hematologic cancer	7.86e-06	6.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACP5—hematologic cancer	7.86e-06	6.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.76e-06	6.48e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CG—hematologic cancer	7.73e-06	6.45e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.58e-06	6.32e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BAD—hematologic cancer	7.57e-06	6.32e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOTCH1—hematologic cancer	7.49e-06	6.26e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—IDH1—hematologic cancer	7.39e-06	6.17e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD80—hematologic cancer	7.34e-06	6.13e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KIT—hematologic cancer	7.33e-06	6.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TXN—hematologic cancer	7.31e-06	6.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.31e-06	6.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.31e-06	6.1e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—hematologic cancer	7.31e-06	6.1e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTPN11—hematologic cancer	7.2e-06	6.01e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CREBBP—hematologic cancer	7.17e-06	5.98e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.15e-06	5.97e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CD44—hematologic cancer	7.14e-06	5.96e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NQO1—hematologic cancer	7.14e-06	5.96e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.99e-06	5.84e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CREB1—hematologic cancer	6.98e-06	5.82e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BRAF—hematologic cancer	6.89e-06	5.75e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.87e-06	5.74e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6R—hematologic cancer	6.81e-06	5.68e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CD—hematologic cancer	6.8e-06	5.67e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CREBBP—hematologic cancer	6.8e-06	5.67e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYCS—hematologic cancer	6.76e-06	5.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	6.72e-06	5.61e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—hematologic cancer	6.71e-06	5.6e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.69e-06	5.58e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.69e-06	5.58e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.52e-06	5.44e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAP2K1—hematologic cancer	6.49e-06	5.41e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CD—hematologic cancer	6.44e-06	5.38e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.44e-06	5.37e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3R1—hematologic cancer	6.42e-06	5.36e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NUP98—hematologic cancer	6.31e-06	5.27e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF2—hematologic cancer	6.17e-06	5.15e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CG—hematologic cancer	6.14e-06	5.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.13e-06	5.11e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.13e-06	5.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3R1—hematologic cancer	6.08e-06	5.08e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NUP214—hematologic cancer	6.08e-06	5.08e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.04e-06	5.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTR—hematologic cancer	5.96e-06	4.97e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.96e-06	4.97e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTP1—hematologic cancer	5.96e-06	4.97e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CB—hematologic cancer	5.92e-06	4.95e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JAK2—hematologic cancer	5.91e-06	4.94e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ENO2—hematologic cancer	5.84e-06	4.88e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MDM2—hematologic cancer	5.77e-06	4.82e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.76e-06	4.81e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CREBBP—hematologic cancer	5.69e-06	4.75e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.67e-06	4.73e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCB1—hematologic cancer	5.64e-06	4.71e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTOR—hematologic cancer	5.62e-06	4.69e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CB—hematologic cancer	5.62e-06	4.69e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD4—hematologic cancer	5.61e-06	4.68e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SDC1—hematologic cancer	5.54e-06	4.62e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.47e-06	4.57e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.47e-06	4.57e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CD—hematologic cancer	5.4e-06	4.5e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—hematologic cancer	5.33e-06	4.45e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1B—hematologic cancer	5.27e-06	4.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTEN—hematologic cancer	5.12e-06	4.27e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3R1—hematologic cancer	5.1e-06	4.25e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—EP300—hematologic cancer	4.88e-06	4.08e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1A—hematologic cancer	4.86e-06	4.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTEN—hematologic cancer	4.85e-06	4.05e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.84e-06	4.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NQO1—hematologic cancer	4.71e-06	3.93e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CD44—hematologic cancer	4.71e-06	3.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CB—hematologic cancer	4.7e-06	3.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EP300—hematologic cancer	4.63e-06	3.86e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SRC—hematologic cancer	4.5e-06	3.76e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYCS—hematologic cancer	4.46e-06	3.72e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.43e-06	3.7e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—hematologic cancer	4.34e-06	3.62e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NRAS—hematologic cancer	4.33e-06	3.61e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.26e-06	3.56e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK3—hematologic cancer	4.15e-06	3.46e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.06e-06	3.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTEN—hematologic cancer	4.06e-06	3.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—hematologic cancer	4.03e-06	3.37e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—hematologic cancer	4.02e-06	3.36e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.93e-06	3.28e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—EP300—hematologic cancer	3.88e-06	3.24e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.77e-06	3.15e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KRAS—hematologic cancer	3.73e-06	3.11e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.72e-06	3.1e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—hematologic cancer	3.61e-06	3.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.61e-06	3.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.61e-06	3.01e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.57e-06	2.98e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—hematologic cancer	3.53e-06	2.94e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—hematologic cancer	3.42e-06	2.86e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.37e-06	2.82e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.19e-06	2.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HRAS—hematologic cancer	3.17e-06	2.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.11e-06	2.6e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—hematologic cancer	3.03e-06	2.53e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—hematologic cancer	2.95e-06	2.46e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—hematologic cancer	2.87e-06	2.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—hematologic cancer	2.8e-06	2.33e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTEN—hematologic cancer	2.69e-06	2.25e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.68e-06	2.24e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—EP300—hematologic cancer	2.57e-06	2.14e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.49e-06	2.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.36e-06	1.97e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—hematologic cancer	2.34e-06	1.96e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—hematologic cancer	2.33e-06	1.94e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.23e-06	1.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.05e-06	1.71e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.9e-06	1.58e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.77e-06	1.48e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—EP300—hematologic cancer	1.69e-06	1.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—hematologic cancer	1.55e-06	1.29e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.25e-06	1.05e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.02e-06	8.54e-06	CbGpPWpGaD
